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Human T cell leukemia virus type 1 (HTLV-1) is the
causative agent of adult T cell leukemia and HTLV-
1-associated myelopathies. In addition to T cells,
HTLV-1 infects cells of the myeloid lineage, which
play critical roles in the host innate response to
viral infection. Investigating the monocyte depletion
observed during HTLV-1 infection, we discovered
that primary human monocytes infected with HTLV-
1 undergo abortive infection accompanied by
apoptosis dependent on SAMHD1, a host restriction
factor that hydrolyzes endogenous dNTPs to below
the levels required for productive reverse tran-
scription. Reverse transcription intermediates (RTI)
produced in the presence of SAMHD1 induced
IRF3-mediated antiviral and apoptotic responses.
Viral RTIs complexed with the DNA sensor STING to
trigger formation of an IRF3-Bax complex leading to
apoptosis. This study provides a mechanistic expla-
nation for abortive HTLV-1 infection of monocytes
and reports a link between SAMHD1 restriction,
HTLV-1 RTI sensing by STING, and initiation of
IRF3-Bax driven apoptosis.
INTRODUCTION
Infection with human T cell leukemia virus type 1 (HTLV-1) affects
approximately 20 million people worldwide (Cook et al., 2013)
and is a major cause of mortality and morbidity in endemic areas
such as southern Japan, the Caribbean basin, Central/South
America, and Western Africa (Ragin et al., 2008). Most infected
individuals are asymptomatic carriers of the virus, although
they remain at risk for opportunistic infections (Verdonck et al.,
2007). Chronic HTLV-1 infection can lead to a number of severe
pathologies associated with poor prognosis, including the
aggressive adult T cell leukemia (ATL), progressive HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/
TSP), uveitis, and infective dermatitis in children (Cook et al.,
2013; Yamano and Sato, 2012). HTLV-1 has a preferential
tropism for CD4+ T cells, while both CD4+ and CD8+ T cells
constitute viral reservoirs in HAM/TSP patients (Cook et al.,422 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 Elsev2013). Unlike most retroviruses, cell-free HTLV-1 is poorly infec-
tious and does not stably infect its primary CD4+ T lymphocyte
target. Rather, HTLV-1 utilizes various cell-to cell transmission
strategies, including transfer of viral assemblies, formation of
virological synapses, or formation of intracellular conduits (Iga-
kura et al., 2003; Pais-Correia et al., 2010; Van Prooyen et al.,
2010). HTLV-1 also infects cells of the myeloid lineage, which
play critical roles in the host innate response to viral infection.
Previous studies have shown that cell-free HTLV-1 particles
can productively infect DC, which then participate in viral trans-
mission to and transformation of CD4+ T cells (Jones et al.,
2008). HTLV-1 infection of DC elicits an early antiviral response
mediated by the production of type I interferon (IFN) (Colisson
et al., 2010), although the number of peripheral DC, as well as
the IFN response, is reduced in chronically infected asymptom-
atic and ATL subjects (Hishizawa et al., 2004). Monocyte precur-
sors that would normally replenish the DC population are unable
to properly differentiate during chronic HTLV-1 infection, and
recent evidence indicates monocyte depletion in HTLV-1 in-
fected patients (Makino et al., 2000; Nascimento et al., 2011).
The molecular consequences of de novo HTLV-1 infection on
host innate immunity inmonocytic cells have yet to be elucidated.
Human myeloid and bystander CD4+ T cells are refractory to
HIV-1 infection, in part because the host restriction factor
SAMHD1 prevents efficient viral DNA synthesis (Baldauf et al.,
2012; Descours et al., 2012; Laguette and Benkirane, 2012;
Laguette et al., 2011). SAMHD1 functions in nondividing cells
as a deoxynucleoside triphosphate triphosphohydrolase, which
hydrolyzes the endogenous pool of deoxynucleoside triphos-
phates (dNTP) to levels below the threshold required for reverse
transcription (Ayinde et al., 2012; Goldstone et al., 2011;
Lahouassa et al., 2012). SAMHD1 was initially characterized in
the context of the autoimmune disorder Aicardi-Goutie`res
syndrome, and genetic mutations that render SAMHD1 nonfunc-
tional result in uncontrolled inflammatory and type I IFN re-
sponses against self DNA (Rice et al., 2009). Primary cells from
these patients are highly susceptible to HIV-1 infection (Baldauf
et al., 2012; Berger et al., 2011; Descours et al., 2012). The Vpx
accessory protein of HIV-2 and its counterpart in certain strains
of SIV antagonize SAMHD1 by inducing proteasome-dependent
degradation (Ayinde et al., 2012; Laguette et al., 2012). HIV-1
restriction mediated by SAMHD1 is overcome by silencing its
expression with Vpx or by the addition of exogenous dN (deox-
ynucleosides) (Baldauf et al., 2012; Descours et al., 2012; Lagu-
ette et al., 2011; Lahouassa et al., 2012).ier Inc.
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SAMHD1 Blocks HTLV-1 Infection via STINGRecognition of evolutionarily conserved molecular structures
shared by pathogens, known as pathogen-associated molecular
patterns (PAMP), is critical for the initiation of innate immune re-
sponses (Kumar et al., 2011). Multiple surface and cytosolic
pathogen recognition receptors (PRR) (Kawai and Akira, 2011)
have now been identified that sense and respond to microbial
infection. Toll-like receptors (TLR) detect distinct PAMP such
as lipopolysaccharide (TLR4), single-stranded (ss) and double-
stranded (ds) RNA (TLR7/8 and TLR3, respectively), and CpG
DNA (TLR9) (Blasius and Beutler, 2010; Kawai and Akira,
2011). The retinoic acid-inducible gene-I (RIG-I)-like receptors
(RLR), which include RIG-I and MDA5, represent another PRR
family that recognizes cytosolic viral RNA (Blasius and Beutler,
2010; Kawai and Akira, 2011). PRR responsible for the detection
of cytosolic DNA include DAI, DDX41, cGAS, and IFI16, all of
which trigger IFN production, as well as AIM2 that stimulates
an inflammasome-dependent secretion of the proinflammatory
IL-1b cytokine (Barber, 2011; Sun et al., 2013). The endoplasmic
reticulum resident adaptor STING functions as a DNA sensor for
bacterial cyclic GTP (Burdette and Vance, 2013) and mediates
detection of viral DNA (Ishikawa and Barber, 2008; Ishikawa
et al., 2009; Zhong et al., 2008). STING can also directly complex
with ss and ds cytoplasmic viral DNA to initiate antiviral signaling
(Abe et al., 2013).
In the present study, we characterized de novo infection of
primary human monocytes by HTLV-1 and demonstrated that
HTLV-1 infection induces SAMHD1-mediated apoptosis in
monocytic cells. We further showed that production of HTLV-1
reverse transcription intermediates (RTI), generated in the pres-
ence of SAMHD1, complexed with the innate immune sensor
STING and initiated IRF3-Bax-directed apoptosis. These results
elucidate the mechanism of HTLV-1 abortive infection of mono-
cytes and link the host restriction factor SAMHD1, the sensing of
retroviral RTI by STING, and the initiation of IRF3-Bax-driven
apoptosis.
RESULTS
Abortive Infection of Primary Monocytes by HTLV-1
Activates Type I IFN Response
To characterize the impact of HTLV-1 infection on the host anti-
viral response in primary human monocytes, we first assessed
the percentage of HTLV-1-infected monocytes at 3 hr postinfec-
tion (hpi), using increasing concentrations of purified HTLV-1
(0–5 mg/ml). Virus binding to monocytes was dependent on the
quantity of HTLV-1, as illustrated by surface staining with anti-
Env (gp46) monoclonal antibodies (Figure 1A); for subsequent
experiments, an HTLV-1 concentration of 2 mg/ml was used,
since >90% of the cells displayed virus binding (Figure 1A)
(91.7 ± 4.8% gp46+ cells; p > 0.05; n = 5). HTLV-1 particles
were efficiently internalized by monocytes, as determined by
intracellular HTLV-1 viral RNA (vRNA) detection at 3 hpi, with
the viral RNA load gradually decreasing over the 120 hr time
course (Figure 1B). HTLV-1 internalization was further demon-
strated by intracellular staining (ICS) for the viral matrix protein
p19 at 24 hpi (Figure 1C, blue histograms) (86.7 ± 6.2% of
p19+ monocytes; p < 0.01 compared to uninfected cells; n =
5). Importantly, viral binding and internalization were eliminated
by pretreating HTLV-1 with anti-gp46 neutralizing mAb or pre-Cell Hosttreating monocytes with 0.1% trypsin (Jones et al., 2005) (Fig-
ure 1C) (p < 0.01 compared to infected cells). The absence of
intracellular Tax protein and virion release indicated that mono-
cytes were not productively infected by HTLV-1 (Figure 1C and
Figure S1, respectively). Monocyte-derived DC, on the other
hand, were productively infected with HTLV-1 (40.6 ± 5.7%
Tax+ cells at 24 hpi) (data not shown).
Despite the nonproductive infection by HTLV-1, monocytes
generated a robust innate immune response, as illustrated by
the induction of multiple parameters of antiviral signaling. An
early increase in phosphorylated interferon regulatory factor 3
(P-IRF3) was detected at 3 hpi (Figure 1D), while increased
expression of STAT1, phosphorylated STAT1 (P-STAT1), inter-
feron-stimulated gene 56 (ISG56), and RIG-I were observed at
24 and 48 hpi.
HTLV-1-Infected Monocytes Undergo Apoptosis
We next evaluated the level of apoptosis in HTLV-1-infected
CD14+ monocytes by Annexin-V staining. At 24 hpi, infected
monocytes displayed higher levels of apoptosis than uninfected
cultures (Figure 2A) (22.9 ± 3.5% versus 8.6 ± 1.3%, respec-
tively; p < 0.01; n = 5), and by 72 hr the percentage of HTLV-1
infected apoptotic cells increased to over 45%. Infection of
monocytes with a low dose of HTLV-1 (0.1 mg/ml) also resulted
in apoptosis in the p19+ population (Figure S2A). Apoptosis
was accompanied by the generation of cleaved caspase-3 (Fig-
ure 2B and Figure S2B) (33.4 ± 12.3% and 11.4 ± 2%, for HTLV-
1-infected and uninfected cells, respectively; p < 0.01; n = 5) and
loss of mitochondrial potential as shown by reduced DiOC6(3) in-
tensity (Figure 2C and Figure S2C) (p < 0.01; n = 5). The pan-cas-
pase inhibitor Z-VAD or the blocking a-gp46 mAb prevented
CLcaspase-3-mediated apoptosis (Figure 2B) and mitochondrial
depolarization (Figure 2C). Z-VAD did not interfere with the inter-
nalization of HTLV-1, as detected by measuring intracellular p19
(Figure 2B, blue histograms) (p > 0.05; n = 5). A strong statistical
correlation between (1) caspase-3 activation and (2) mito-
chondrial depolarization and apoptosis was confirmed by the
nonparametric Spearman test (Figure 2D) (r = 0.7845 and
0.9036, respectively, for 1 and 2; p < 0.0001; n = 25). Expression
of mitochondrial pro- and antiapoptotic molecules were also
analyzed; increased Bax expression and caspase-9 cleavage
were observed in infected monocytes (Figure 2E) (p < 0.05 and
p < 0.01, respectively; n = 3), while expression of Bcl-2 family
members Bim, Noxa, Bcl-2, and Mcl-1 were unchanged. In the
above experiments, we did not observe death by necrosis or
an effect of necrostatin-1 on infected monocytes (Figure S2D).
Cleaved caspase-1 and bioactive IL-1b were detected after
infection, indicating activation of the inflammasome (Figure S2E).
To investigate caspase-1-associated pyroptosis, HTLV-1-in-
fected cells were treated with YVAD, a selective inhibitor of cas-
pase-1; a minor but significant improvement of cell survival was
observed (Figure S2F).
A Requirement for SAMHD1 in HTLV-1-Driven Apoptosis
in Infected Monocytes
The above observations, detailing abortive HTLV-1 infection of
monocytes, are reminiscent of the consequences of host restric-
tion by SAMHD1 during HIV-1 infection (Baldauf et al., 2012;
Descours et al., 2012; Doitsh et al., 2010; Laguette et al.,& Microbe 14, 422–434, October 16, 2013 ª2013 Elsevier Inc. 423
Figure 1. Abortive Infection of Monocytes by HTLV-1 Activates an Antiviral Response
(A–C) Purified monocytes were infected with HTLV-1 for 3 hr and then cocultured with the autologous CD14neg PBMCs for 120 hr pi. (A) Virus binding to
monocytes at 3 hpi in response to various HTLV-1 concentrations, analyzed by flow cytometry with anti-gp46 Abs. P values were determined based on the
comparison with cells infected with 5 mg/ml HTLV-1 (n = 5). (B) At 3–120 hpi, total RNA was extracted and analyzed for HTLV-1 viral load using primers located in
the 50 UTR of HTLV-1 genome (Table S1). Equivalent vRNA amounts were normalized to b-actin mRNA and calculated as fold change from the level of uninfected
monocytes (arbitrary set as 1). Jurkat and MT-2 cells were used as negative and positive control, respectively (n = 5). (C) At 3, 24, and 48 hpi, levels of HTLV-1
binding, viral internalization, and de novo production of viral proteins were assessed by gp46 surface staining, p19, and Tax ICS, respectively. Histograms are
representative of raw data from five independent experiments. The mean relative expressions ± SD for all conditions are indicated. MT-2 and Jurkat cells were
used as positive and negative controls for all staining, respectively.
(D) p24 expression and type I IFN responses were examined by immunoblotting (n = 3). See also related Figure S1.
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SAMHD1 Blocks HTLV-1 Infection via STING2011), prompting us to investigate whether SAMHD1 functioned
similarly to restrict HTLV-1 infection. Small interfering RNA
(siRNA)-mediated silencing of SAMHD1 resulted in a 72 ±
11.8% reduction in SAMHD1 expression (Figure 3A), but did
not alter HTLV-1 internalization in control or siRNA-transfected
monocytes (>95.5%) (Figure 3B, right histograms). Following424 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 ElsevHTLV-1 infection, induced apoptosis was also reduced by
70% in SAMHD1-silenced monocytes compared to control
siRNA-treated monocytes (Figure 3B) (p < 0.01; n = 5). The cor-
relation between inhibition of SAMHD1 expression and inhibition
of HTLV-1-induced apoptosis in primary monocytes was signif-
icant (Figure 3C) (r = 1; p = 0.0167; n = 5, Spearman test).ier Inc.
Figure 2. HTLV-1-Infected Monocytes Undergo Mitochondrial-Dependent Apoptosis
(A) The percentage of apoptosis on gated CD3CD14+monocytes was assessed by Annexin-V staining at 3–120 hpi. P values were determined by the com-
parison with uninfected cells (n = 5).
(B) Levels of Annexin-V, CLcaspase-3, and p19 expression determined at 48 hpi, treated or not with Z-VAD or with a-gp46 mAb. Representative histograms from
five independent experiments are shown above. Data are represented as mean ± SD.
(C) At 48 hpi, the loss of mitochondrial membrane potential in the presence or absence of Z-VAD or a-gp46 mAb was evaluated by flow cytometry using the fluo-
rescent dye DiOC6(3). Results shown represent the percentage of CD3
CD14+DiOC6(3)
low monocytes, as indicated above in the representative histograms (n = 5).
(D) The correlations between the percentage of apoptotic monocytes and (1) CLcaspase-3 expression or (2) mitochondrial depolarization were calculated in
infected monocytes during the course of the coculture (n = 25; Spearman test).
(E) Expression levels of p24, Bcl-2 family members, and caspase-9 cleavage were assessed by immunoblotting at 3 hpi (n = 3). Data are represented as mean ±
SD. See related Figure S2.
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Figure 3. SAMHD1 Drives Apoptosis in HTLV-1-Infected Monocytes
(A–C) Monocytes were transfected with control or SAMHD1 siRNA for 72 hr, and then infected with HTLV-1 for 48 hr. (A) Efficiency of SAMHD1 silencing was
determined at day 3 by immunoblotting (n = 5). No changes were observed in total ERK2 expression. (B) Levels of apoptosis and intracellular p19 on transfected
CD14+ monocytes at 48 hpi. Results represent the HTLV-1-induced apoptosis determined on transfected monocytes using the formula: % of apoptosis in in-
fected cells % of apoptosis in uninfected cells. Data are expressed as mean ± SD for five independent experiments, including the inhibition of apoptosis (%)
when SAMHD1 was silenced. Flow histograms on the right are representative of raw data. (C) Correlation between the inhibition of SAMHD1 expression and
HTLV-1-induced apoptosis determined on transfected monocytes (n = 5 [values from (A) and (B)]; Spearman test).
(D) Levels of apoptosis determined in the presence of increasing doses of exogenous dN at 48 hpi. Percentage of apoptosis inhibition determined in the presence
of dN are also indicated in blue. Statistical analyses are based on the comparison to untouchedmonocytes, except for those indicated in bold, that are calculated
when compared to HTLV-1-infected, non-dN-treated monocytes (n = 5). Data are represented as mean ± SD. See related Figure S3.
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SAMHD1 Blocks HTLV-1 Infection via STINGThe deoxynucleoside triphosphate triphosphohydrolase func-
tion of SAMHD1 blocks reverse transcription of retroviral RNA by
depleting the dNTP pool required for complete reverse transcrip-
tion (Ayinde et al., 2012; Goldstone et al., 2011; Hollenbaugh
et al., 2013; Kim et al., 2012; Lahouassa et al., 2012), an effect
reversed by the addition of exogenous dN (Lahouassa et al.,
2012). To explore the relationship between the triphosphohydro-
lase activity of SAMHD1 and apoptosis, primary monocytes
were infected with HTLV-1 in the presence of increasing concen-
trations of exogenous dN (0–100 nM). SAMHD1-mediated
apoptosis was inhibited by addition of exogenous dN in a
dose-dependent manner (Figure 3D), with apoptosis reduced
to control levels in monocytes treated with 100 nM dN (>80% in-
hibition of apoptosis). We did not observe de novo Tax expres-
sion following SAMHD1 knockdown or dN treatment in infected426 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 Elsevmonocytes at 48 hpi (n = 3; data not shown). These results
demonstrate that nucleotide pool depletion, mediated by
SAMHD1 function, correlates directly with HTLV-1-induced
apoptosis.
HTLV-1-Induced Apoptosis Correlates with the
Generation of Cytosolic RTI
Previous studies demonstrated that incomplete synthesis of
retroviral DNA triggered a proapoptotic response in HIV-1-in-
fected bystander CD4+ T cells (Doitsh et al., 2010). To assess
the presence of RTI in HTLV-1-infected monocytes, viral DNA
was measured in total versus nuclear fractions at 3–120 hpi;
HTLV-1 RTI were detected only in the total fraction (Figure 4A
and Figures S3A and S3B), indicating that viral DNA synthesis
was initiated in the cytosol, but was not fully reverse transcribedier Inc.
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Figure 4. Cytosolic RTI Induce Monocyte
Apoptosis Following HTLV-1 Infection
(A) At 24 hpi, DNA was extracted from total (TF)
and nuclear (NF) fractions in monocytes. Viral
load was determined by qPCR using 50 UTR
primers and normalized to erv-3. Results shown
represent the relative fold change and statistical
analyses, compared to uninfected monocytes
(n = 5). Purity of NF was determined by immu-
noblotting using antibodies against nuclear
(Thoc-1 and HistoneH3) and cytosolic (COX-IV)
proteins.
(B) Monocytes were transfected with SAMHD1
siRNA, treated with exogenous 100 nM dN, then
treated as in (A). Results represent relative fold
change compared to uninfected cells, treated with
control siRNA (n = 5).
(C) Fold change of vDNA was determined at 48 hpi
using several primer pairs, relative to infected
monocytes without AZT.
(D) Inhibition of apoptosis mediated by AZT is
indicated in blue.
(E) Fold change of vDNA performed in monocytes
expressing or not SAMHD1 at 24 hpi using several
primer pairs. Data are in (C) and (D) are repre-
sented as mean ± SD.
(F) The addition of HTLV-1 RTI in monocytes ini-
tiates apoptosis. Purified monocytes were trans-
fected with HTLV-1 ss or dsDNA90 or scrambled
ssDNA. At 48 hr, cells were labeled with Annexin-
V-V450, CD14-APC H7, and streptavidin-APC.
Streptavidin-APC ICS distinguished between
monocytes that were vDNAneg (purple) or vDNA+
cells (green) in the same sample. Elect. = elec-
troporated only; scram. = scrambled ssDNA90.
Values represent the percentages of normal-
ized apoptosis indicated by the formula: % of
apoptosis in RTI-transfected monocytes with
siRNA  % of apoptosis in electroporated-only
cells. Apoptosis resulting from electropora-
tion averaged between 15% and 19%. Flow
histograms are representative of raw data from
five independent experiments. See related
Figure S3.
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SAMHD1 Blocks HTLV-1 Infection via STINGand did not reach the nucleus (Nisole and Saı¨b, 2004). Silencing
SAMHD1 expression or treatment with exogenous dN led to the
detection of HTLV-1 DNA in the nucleus, as well as integrated
provirus, in infected monocytes (Figure 4B and Figure S3C).
Several primer pairs were designed to monitor sequential
steps in HTLV-1 reverse transcription, including strong-stop
DNA (50utr), and DNA elongation (env or gag) (Figure 4C, upper
schematic, and Table S1) (Doitsh et al., 2010). Primary mono-
cytes were treated with 5mM azidothymidine (AZT), a nucleoside
analog reverse transcriptase inhibitor that prevents elongation of
reverse-transcribed DNA after initiation (Doitsh et al., 2010), and
then infected with HTLV-1. AZT treatment had no inhibitory ef-
fect on the initiation of HTLV-1 reverse transcription (Figure 4C),
as detected with the 50utr primers (green), whereas DNA strand
elongation was progressively inhibited, as detected using env
(blue) and gag (orange) region-specific probes (Figure 4C)
(35.5 ± 31.3% and 65.5 ± 22.7% inhibition, respectively; p <
0.01; n = 5). Following HTLV-1 infection, apoptosis in monocytesCell Hosttreated with AZT was reduced by >40% compared to infected
cells without AZT (Figure 4D) (41.8 ± 12.3%; p < 0.05; n = 5).
These results demonstrate that AZT blocked HTLV-1 DNA elon-
gation and suggested that cytosolic RTI generation was linked
with virus-mediated apoptosis. These primers were also used
in the context of SAMHD1 silencing, to investigate the produc-
tion of early- versus late-stage RTI. SAMHD1 knockdown led
to a decrease in the generation of total and early transcripts
(green [50utr]; 1.45 ± 0.41-fold decrease), concomitant with an
accumulation of late reverse transcription products (orange
[gag]; 1.39 ± 0.27-fold increase) (Figure 4E).
To determine if HTLV-1 RTI directly mediated apoptosis, syn-
thetic ss or ds 90 nt HTLV-1 DNA (vDNA), conjugated with biotin,
were introduced into primary monocytes. Monocytes harboring
HTLV-1 ss or dsDNA90 (vDNA
+ cells; green histograms) under-
went apoptosis (59.2 ± 3.5% and 48.9 ± 6.9%, respectively),
whereas vDNA-free monocytes did not undergo apoptosis (pur-
ple histograms; 30% apoptosis in cells electroporated only, or& Microbe 14, 422–434, October 16, 2013 ª2013 Elsevier Inc. 427
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SAMHD1 Blocks HTLV-1 Infection via STINGtransfected with digested ssDNA90 [data not shown]) (Figure 4E).
The transfection of monocytes with scrambled RTI (whose
sequence was generated by randomizing the U5 sequence) did
not result in apoptosis, confirming the specificity of HTLV-1
RTI to induce apoptosis (Figure 4F). Overall, these results pro-
vide evidence for a direct contribution of cytosolic RTI to
HTLV-1-induced apoptosis.
HTLV-1 RTI Signal via STING to Induce Apoptosis
and the IFN Response
The endoplasmic reticulum resident transmembrane sensor
STING (stimulator of interferon genes) is central to the generation
of an innate immune response, through its capacity to directly
bind viral and bacterial DNA (Abe et al., 2013; Burdette and
Vance, 2013; Ishikawa and Barber, 2008; Ishikawa et al.,
2009). Given the importance of STING, we next examined
whether STING could recognize and complex with HTLV-1 RTI.
Using streptavidin beads to pull down biotinylated HTLV-1
DNA, we demonstrated that STING was precipitated from pri-
mary monocytes via interactions with ss or dsDNA90 (Figure 5A).
Furthermore, the formation of the complex between STING and
HTLV-1 DNA was associated with the induction of type I IFN
signaling and apoptosis, as illustrated by increased expression
of RIG-I, ISG56, and Bax (Figure 5A) (p < 0.01; n = 3). Transfec-
tion of monocytes with scrambled RTI resulted in STING pull-
down and the induction of ISGs. However, no increase in Bax
expression was observed in these cells. No complex formation
was observed between HTLV-1 RTI and the RNA sensor RIG-I
(Figure 5A).
To determine whether cytosolic detection of HTLV-1 RTI by
STING was involved in triggering apoptosis, STING-specific
siRNA was introduced into primary monocytes, resulting in
65% inhibition of STING expression (Figure 5B) (p < 0.01; n =
5). Knockdown of STING in primary monocytes resulted in a sig-
nificant improvement in cell survival. In multiple experiments, a
55%–60% inhibition of apoptosis was observed (Figure 5C)
(p < 0.01 compared to control siRNA-treated cells; n = 5),
whereas silencing of RIG-I had no effect on HTLV-1-induced
apoptosis (Figures S4). A positive correlation between the inhibi-
tion of STING expression and HTLV-1-induced apoptosis was
established using the nonparametric Spearman test (Figure 5D)
(r = 1; p = 0.0167; n = 5). Altogether, these results indicate that
HTLV-1 RTI, generated in primary monocytes in a SAMHD1-
dependent manner, complex with the DNA sensor STING and
initiate apoptosis.
HTLV-1 RTI Trigger Mitochondrial Apoptosis through
IRF3-Bax Signaling
HTLV-1 infection of monocytes stimulated IRF3 activation and
induction of proapoptotic Bax (Figures 1D and 2E), suggesting
that HTLV-1 may trigger apoptosis via a mechanism involving
the formation of a proapoptotic complex between IRF3 and
Bax (Chattopadhyay et al., 2010, 2011). To determine whether
STING recognition of HTLV-1 RTI could trigger apoptosis
through IRF3-Bax signaling, we measured Bax and ISG expres-
sion as well as IRF3 phosphorylation in infected monocytes
knocked down for STING expression. All parameters—Bax,
P-IRF3, RIG-I, and ISG56 expression—were inhibited, 95.1 ±
8.5%, 72.1 ± 13.3%, 66.2 ± 48%, and 64.5 ± 29.3%, respec-428 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 Elsevtively, by STING knockdown (p < 0.01 compared to infected cells
treated with control siRNA; n = 3) (Figure 6A), thus supporting a
role for STING in regulating both the antiviral and apoptotic
responses. Similarly, we observed a 73 ± 15.8% inhibition of
Bax-expressing monocytes when STING was silenced (Fig-
ure S5). As with de novo HTLV-1 infection, the addition of cyto-
solic ss or dsDNA90 led to increased Bax expression (Figure 6B,
input blots) (p < 0.05; n = 3). Both HTLV-1 infection and addition
of biotinylated ss or dsDNA90 resulted in the generation of a com-
plex between IRF3 and Bax (Figure 6B), whereas no IRF3-Bax
complex was observed in monocytes transfected with scram-
bled RTI. The formation of this proapoptotic complex required
both SAMHD1 and STING expression, since RNAi-mediated
silencing of either target not only decreased Bax expression,
but also abrogated physical association between IRF3 and Bax
(Figure 6C).
Next, a multi-parametric antibody cocktail was generated to
measure the levels of Annexin-V, Bax, and DiOC6(3) costaining
on gated CD14+ monocytes. Infected monocytes expressing
Bax (red subset) displayed higher levels of mitochondria depo-
larization and Annexin-V costaining, compared to the green
Baxneg cells (Figure 6D) (74.3 ± 24.8% and 34.3 ± 5.9%
DiOC6(3)
low Annexin-V+ cells, respectively; p < 0.01; n = 5).
Furthermore, siRNA-mediated silencing of Bax expression
reduced the level of apoptosis by 60%, thus confirming the
involvement of Bax in HTLV-1 driven monocyte cell killing
(Figure 6E).
HIV-1DNARecognition bySTING Induces aProapoptotic
Response
Finally, we examined whether STING-mediated recognition of
RTI corresponding to strong-stop HIV-1 DNA also led to
monocyte depletion through IRF3-Bax driven apoptosis. HIV-1
ssDNA90 RTI was introduced into primary monocytes for 3 hr;
IRF3 phosphorylation and Bax expression were increased 7-
to 10-fold with the HIV-1 RTI (Figure 7A) (p = 0.0053 and p =
0.0115, respectively, compared to RTI-free monocytes; n = 3).
Biotinylated HIV-1 ssDNA90 and STING, but not RIG-I, were
also pulled down in association with HIV RTI (Figure 7B). As
with HTLV-1, the addition of biotinylated HIV-1 ssDNA90 resulted
in the generation of a heterodimeric IRF3-Bax complex (Fig-
ure 7C) and monocytes containing HIV-1 RTI also displayed
significantly higher levels of mitochondria-dependent apoptosis
(Figure 7D). Overall, these data demonstrate that retroviral RTI
recognition by STING induces mitochondria-dependent
apoptosis via the formation of the proapoptotic IRF3-Bax heter-
odimer (Figure S6).
DISCUSSION
In this study, we demonstrate that de novo HTLV-1 infection ini-
tiates an abortive infection of primary monocytes and triggers
mitochondrial depolarization and caspase-3-dependent cell
death. HTLV-1 infection also stimulated induction of a type I
IFN response, mediated through IRF3 activation, and triggering
of Jak-STAT1 signaling. HTLV-1-induced apoptosis in mono-
cytes was dependent on the triphosphohydrolase activity of
SAMHD1, since silencing its expression or the introduction of
exogenous dN in HTLV-1-infected monocytes significantlyier Inc.
AB C
D
Figure 5. STING Complex Formation with HTLV-1 DNA Induces Apoptosis in Monocytes
(A) Monocytes were transfected with HTLV-1 ss or dsDNA90 or scrambled ssDNA for 6 hr; as a negative control, 1 mg HTLV-1 ssDNA was incubated with 1 ml
DNase (Ambion) for 1 hr at 37C. STING and RIG-I pull-down were performed from monocyte lysates via interactions with biotinylated DNA (Experimental
Procedures). Input lysates were also analyzed by immunoblot for STING, Bax, b-actin, and ISG expression (n = 3).
(B–D) STING regulates the premature death of infected monocytes. Purified monocytes were transfected with STING siRNA for 72 hr and (B) the efficiency of
STING silencing was determined via immunoblotting. (C) Annexin-V staining was determined on transfected CD14+ monocytes at 48 hpi. Values represent the%
HTLV-1-induced apoptosis as determined by the formula: % apoptosis in infected cells  % apoptosis in uninfected cells. Inhibition of HTLV-1-mediated
apoptosis following STING silencing is indicated in blue. Flow histograms shown on the right side are representative of raw data from five independent ex-
periments. Data are represented as mean ± SD. (D) Correlation between inhibition of STING expression and HTLV-1-mediated apoptosis on transfected
monocytes (n = 5; Spearman test). See related Figure S4.
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Figure 6. STING Activation Leads to the
Formation of an IRF3-Bax Complex
(A) Monocytes were transfected with STING
siRNA, and expression of viral and host proteins
(p24, STING, Bax, ISG, and p-IRF3) was deter-
mined by immunoblotting at 3 and 48 hpi.
Representative blots from three independent
experiments are shown.
(B and C) Anti-Bax co-IPs were performed at 6 hpi
(B) following in vitro infection or transfection with
HTLV-1 DNA or (C) in the context of (1) SAMHD1
and (2) STING silencing. Inputs were also
analyzed for the expression of several proteins. * =
crosslinked isotype IgG1 antibody (iso. IgG) used
during co-IP as negative control; performed on
monocytes transfected with ssDNA90.
(D) At 24 hpi, a multi-parametric antibody cocktail
with DiOC6(3) dye, Annexin-V-V450, anti-CD14-
APC H7, and anti-Bax-APC antibodies was used
on cocultured monocytes (n = 5). Anti-Bax anti-
body was conjugated to Alexa-647 dye using the
Zenonmouse IgG1 labelingkit. Isotype IgG1control
was used to determine Bax expression. Results
represent a flow cytometry gating strategy based
on HTLV-1-infected monocytes transfected with
control siRNA. Baxneg (green) versus Bax+ mono-
cytes (red) were analyzed for mitochondrial
depolarization and apoptosis. Percentages of
DiOC6(3)
lowAnnexin-V+ cells were indicated for
both subsets. Data are represented asmean ± SD.
(E)Monocyteswere transfectedwithBax siRNA for
3 hr prior to HTLV-1 infection. Levels of HTLV-1-
induced apoptosis were then investigated at
48 hpi. Results are expressed as mean ± SD for
three independent experiments; included in blue is
the inhibition of apoptosis during Bax silencing.
Bax knockdown was confirmed by immunoblot-
ting 48 hpi. Data are represented as mean ± SD.
See related Figure S5.
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cytoplasm of infected monocytes, and it was only after inhibition
of SAMHD1 expression that HTLV-1 DNA was detected in the
nucleus. The presence of RTI in the cytoplasm was sensed by
the ER resident DNA sensor STING. Because of the involvement
of STING in the type I IFN response, we examined the fate of IRF3
and detected the formation of an IRF3-Bax complex, which was
responsible for the mitochondrial depolarization and apoptosis.
These experiments provide a mechanistic explanation for abor-
tive retroviral infection of monocytes and establish a link be-
tween SAMHD1 restriction, sensing of retroviral RTI by STING,
and the initiation of IRF3-Bax-induced apoptosis. The scope of
these observations was further extended by the demonstration
that HIV-1 RTI also complexed with STING and triggered
apoptosis in the same manner (summarized in Figure S6).
The analogy between the current results and restriction of
HIV-1 by SAMHD1 is striking, and several studies have detailed
the capacity of SAMHD1 to limit HIV-1 replication in quiescent
CD4+ T cells and myeloid cells (Baldauf et al., 2012; Descours430 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 Elsevier Inc.et al., 2012; Laguette and Benkirane,
2012; Laguette et al., 2011). Prior to the
characterization of the role of SAMHD1,Doitsh et al. had demonstrated that abortive HIV-1 reverse tran-
scription in resting tonsil CD4+ T cells resulted in apoptotic cell
death, triggered by the accumulation of incomplete HIV-1
reverse transcripts (Doitsh et al., 2010). It has since become
clear that SAMHD1 is involved in restricting HIV-1 reverse tran-
scription through its dNTP triphosphohydrolase activity, which
depletes the intracellular pool of dNTP (Ayinde et al., 2012; Gold-
stone et al., 2011; Lahouassa et al., 2012). The intracellular dNTP
pool appears to be an important rate-limiting factor for retroviral
reverse transcription, and SAMHD1 critically modulates this pro-
cess. SAMHD1 is highly active in monocytes that have low levels
of intracellular dNTP (Kaushik et al., 2009; Triques and Steven-
son, 2004). In the presence of active SAMHD1, nuclear or inte-
grated HTLV-1 DNA was never detected in infected monocytes,
whereas SAMHD1 silencing or restoration of the dNTP pool
resulted in the inhibition of virus-induced apoptosis, as well as
completion of vDNA synthesis and nuclear translocation. Simi-
larly, reduction of cytoplasmic HTLV-1 RTI levels by AZT also
improved cell viability. To investigate directly a role for RTI in
Figure 7. STING Recognition of HIV-1 RTI
Leads to IRF3-Bax Interaction and Mito-
chondrial-Dependent Apoptosis
(A) Expression of STING, IRF3, P-IRF3, and Bax
proteins were assessed by immunoblotting on
monocytes transfected with HIV-1 ssDNA90
for 3 hr.
(B and C) STING pull-down (B) and anti-Bax co-IP
(C) were performed on monocytes transfected
with HIV-1 ssDNA90 (n = 3).
(D) Monocytes treated with HIV-1 ssDNA90 dis-
played higher levels of mitochondria-dependent
apoptosis. At 48 hpi, levels of Annexin-V, mito-
chondria depolarization (% of DiOC6(3)
low cells),
and costaining were assessed on gated CD14+
monocytes in the presence of HIV-1 RTI.
Results show the percentages of HIV-1-induced
apoptosis and Bax expression, determined by the
formula: % of staining in HIV-1 RTI-transfected
monocytes  % of staining in monocytes elec-
troporated alone. Flow histograms shown on the
right are representative of raw data from five in-
dependent experiments. Data are represented as
mean ± SD. See related Figure S6.
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region of HTLV-1 was introduced into monocytes, and it trig-
gered apoptosis in a manner similar to infection.
One of the outstanding questions raised by these studies is:
how does SAMHD1-mediated restriction of retroviral replication
initiate apoptosis and impact the host innate response to retro-
viral infection? Our experiments provide evidence that the
endoplasmic reticulum resident adaptor STING triggers both
processes through IRF3 activation. STING is known to regulate
type I IFN immunity following recognition of pathogen DNA
(Ishikawa et al., 2009); its ability to directly interact with viral
DNA was characterized recently, and STING was shown to be
the primary sensor involved in DNA recognition (Abe et al.,
2013). Although STING was readily pulled down in complex
with RTI, we cannot exclude the involvement of other DNA sen-
sors such as MRE11 (Kondo et al., 2013), DDX41 (Zhang et al.,
2011), or IFI16 (Unterholzner et al., 2010). Importantly, the DNA
sensor cGAS was recently shown to sense HIV-1 and other
retroviruses via the recognition of retroviral DNA reverseCell Host & Microbe 14, 422–434,transcriptase intermediates, leading to
STING-mediated activation of IRF3-
dependent antiviral activity (Gao et al.
2013; Sun et al., 2013). The release of
type 1 IFN and/or proinflammatory cyto-
kines during HTLV-1 infection could also
contribute to the induction of apoptosis
in monocytes.
Complex formation between STING
and HTLV-1 RTI initiated apoptosis
through the formation of an IRF3-Bax
complex (Chattopadhyay et al., 2010,
2013). Following HTLV-1 infection of
monocytes, we detected an IRF3-Bax
complex formation that was abrogated
in monocytes when STING expressionwas silenced, thus identifying STING signaling as an additional
pathway involved in IRF3-Bax induction. That IRF3 activation
can promote both apoptotic and antiviral signaling was demon-
strated in earlier studies in which constitutively active forms of
IRF3 and IRF7 were transduced into primary macrophages
(Goubau et al., 2009). Transcriptional profiling and biological
characterization of transduced human macrophages demon-
strated that IRF3 initiated an antiviral response, but also rapidly
induced cell death through the upregulation of a subset of
proapoptotic genes (Goubau et al., 2009).
We observed similar apoptotic mechanisms associated with
STING binding and IRF3-Bax induction of apoptosis when HIV-
1 RTI were introduced into monocytes, arguing in favor of the
generality of the SAMHD1-STING initiation of apoptotic signaling
in human retroviral infection (Figure 7). This observation, how-
ever, is not applicable in the context of HIV-2 that expresses
Vpx; the physical interaction of SAMHD1 with Vpx recruits the
Cul4-DDB1-DCAF1 complex to drive its proteasomal degrada-
tion (Descours et al., 2012; Laguette et al., 2011; LahouassaOctober 16, 2013 ª2013 Elsevier Inc. 431
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recognition of HIV-1 replicative intermediates by STING as a viral
evasion mechanism (Yan et al., 2010).
No correlation was observed between HTLV-1-induced
apoptosis and expression levels of SAMHD1 (data not shown),
consistent with studies where HIV-1 restriction was not solely
associated with SAMHD1 expression levels (Descours et al.,
2012). In fact, monocyte-derived DC are productively infected
by HTLV-1 (Abe et al., 2013; Jones et al., 2008), despite
SAMHD1 expression (Laguette et al., 2011). Moreover, inmacro-
phages and cycling CD4+ T cells, HTLV-1 infection was not
blocked by SAMHD1 and led to Tax production (Gramberg
et al., 2013), indicating that SAMHD1 function differs in other
cell contexts. It is likely that regulation of SAMHD1 restriction
depends on several retroviral and host parameters including
posttranslational modifications, cellular cofactors, and splice
variations (Descours et al., 2012; Welbourn et al., 2012). In this
regard, it was recently demonstrated that SAMHD1 activity is
modulated by phosphorylation status. Cyclin A2/CDK1 phos-
phorylated SAMHD1 at Thr592 SAMHD1 in cycling cells, and
phosphorylation at Thr592 correlated with loss of restriction
(Cribier et al., 2013; White et al., 2013). Furthermore, type 1
IFN treatment reduced Thr592 phosphorylation, indicating a
link between SAMHD1 phosphorylation, antiviral activity, and
innate immune signaling (Cribier et al., 2013). A Thr592 phospho-
mimetic SAMHD1 mutant did not restrict HIV-1 replication,
despite dNTPase activity, oligomer formation, and nuclear local-
ization (White et al., 2013). These experiments identify phosphor-
ylation of SAMHD1 at Thr592 by cyclin A2/CDK1 as an important
regulatory mechanism and highlight the need for further studies
to elucidate the mechanisms that regulate SAMHD1 activity and
function.
The demonstration that cytoplasmic RTI contributes to the
elimination of HTLV-1-infected monocytes may have important
consequences for human retroviral pathogenesis. The clearance
of infected monocytes may prevent transmission to CD4+
T cells, and may also deplete the precursor pool of myeloid
dendritic cells that play a crucial role in controlling HTLV-1 infec-
tion (Rahman et al., 2011). Individuals suffering from ATL or
HAM/TSP possess a lower absolute number of DC than healthy
individuals (Azakami et al., 2009; Hishizawa et al., 2004), and
HTLV-1-infectedmonocytes also exhibit defective differentiation
into DC (Makino et al., 2000; Nascimento et al., 2011). These
factors may influence the development of HAM/TSP or ATL in
HTLV-1 infected individuals, thus emphasizing the need to
better understand the early host restriction of HTLV-1 infectivity
by SAMHD1.EXPERIMENTAL PROCEDURES
Products
RPMI-1640 media, FBS, and antibiotics were provided by Wisent Technolo-
gies. All monoclonal antibodies (mAbs) and products used for flow cytometry
were purchased fromBiolegend, except for anti-cleaved caspase-3-PEmAbs,
Annexin-V buffer 10X, and Annexin-V-V450 obtained from Becton Dickinson.
Anti-p19 mAbs (clone TP-7) was purchased from ZeptoMetrix Corporation,
whereas anti-gp46 mAbs (clone 67/5.5.13.1) was purchased from Abcam.
Anti-Tax-FITC mAbs (clone LT4) was generously provided by Dr. Yuetsu
Tanaka (Kitasato University, Kanagawa, Japan). All antibodies included in
western blotting analyses came from Cell signaling Biotechnology Inc., except432 Cell Host & Microbe 14, 422–434, October 16, 2013 ª2013 Elsevfor anti-Bax mAbs (Santa Cruz Biotechnology Inc.). Pan-caspase inhibitor
Z-VAD-FMK (Z-VAD) was purchased from R&D Systems. All cell lines were
obtained from the ATCC.
Purification of Monocytes
Leukaphereses from healthy donors were obtained from the Royal Victoria
Hospital, Montreal (QC, Canada), with informed consent of the patients and
in agreement with the Royal Victoria Hospital, the Jewish General Hospital,
and McGill University Research Ethics Committee.
HTLV-1 Purification and In Vitro Infection
HTLV-1 viruses were purified from MT-2 supernatants. Cells were seeded
overnight in complete RPMI (2 3 106 cells/ml). Supernatants were collected
and ultracentrifuged for 2 hr at 30,0003 g at 4C. The viral pellet was
resuspended in complete RPMI, and HTLV-1 particles were quantified by
gag p19 ELISA assays (ZeptoMetrix). A total of 200,000 purified mono-
cytes were incubated with 2 mg HTLV-1 for 3 hr at 37C in 0.5 ml RPMI
complete with or without 100 mM Z-VAD-FMK. To specifically block HTLV-
1 infection, neutralizing anti-gp46 mAbs (at 10 mg/ml; Abcam) were incu-
bated 30 min at 4C with HTLV-1 prior in vitro infection. At 3 hpi, monocytes
were washed twice in complete RPMI and then cocultured with 8 3 105
autologous monocyte-depleted PBMCs (1 ml complete RPMI; [HTLV-1] =
2 mg/ml).
Western Blotting
Protein lysates (2–10 mg) frommonocytes were subjected to western blot anal-
ysis as previously described (Olie`re et al., 2010).
Small Interfering RNA Assays
A total of 107 purified monocytes were electroporated in the presence of
control or specific siRNA using Nucleofactor II technology according the
manufacturer’s protocol (Amaxa human monocyte nucleofactor kit).
Biotinylated Retroviral DNA90 Assay
Retroviral DNA was produced by Integrated DNA Technologies. HTLV-1
ssDNA90 is the reverse complement of the 5
0 UTR region (315–404 of complete
HTLV-1 genome; NCBI) that is 90 bases long and conjugated with biotin on the
50 end. A total of 107 monocytes were transfected with 10 mg vDNA90 for 24 hr
in RPMI + 30%FBS in the absence of antibiotics. Monocytes werewashed and
then cocultured in complete RPMI with CD14neg PBMCs.
STING Pull-Down and Bax Coimmunoprecipitation
Monocytes were infected with HTLV-1 or transfected with biotinylated RTI for
6 hr (pull-down) or 3 hr (co-IP). Monocytes were lysed using CHAPS buffer with
protease inhibitors as previously described (Samuel et al., 2010). Protein (3 mg)
was collected and referred to as the ‘‘input’’ fraction.
Statistical Analysis
Statistical analyses were performed using the nonparametric Mann-Whitney U
test, assuming independent samples. However, differences among the treat-
ment groups performed with n = 3 samples were analyzed by the parametric
unpaired Student’s t test. P values of less than 0.05 were considered statisti-
cally significant. ***, p < 0.001; **, p < 0.01, and *, p < 0.05.
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